The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Prevalence of Symptomatic Androgen Deficiency in Men
Abstract
Context: Despite recognition that androgen deficiency in men should be defined according to biochemical and clinical criteria, most prevalence estimates are based on low testosterone levels alone. Objective: The objective of this study was to examine the association between symptoms of androgen deficiency and low total and calculated free testosterone levels and estimate the prevalence of symptomatic androgen deficiency in men. Design: This study was a population-based, observational survey. Participants: A total of 1475 Black, Hispanic, and white men, between the ages of 30–79 yr, with complete data on testosterone, SHBG, and symptoms of androgen deficiency, and who are not taking medications that impact sex steroid levels were randomly selected from the Boston Area Community Health Survey. Outcome: Outcomes were measured as symptomatic androgen deficiency, defined as low total (<300 ng/dl) and free (<5 ng/dl) testosterone plus presence of low libido, erectile dysfunction, osteoporosis or fracture, or two or more of following symptoms: sleep disturbance, depressed mood, lethargy, or diminished physical performance. Results: Mean age of the sample was 47.3 ± 12.5 yr. Approximately 24% of subjects had total testosterone less than 300 ng/dl, and 11% of subjects had free testosterone less than 5 ng/dl. Prevalence of symptoms were as follows: low libido (12%), erectile dysfunction (16%), osteoporosis/fracture (1%), and two or more of the nonspecific symptoms (20%). Low testosterone levels were associated with symptoms, but many men with low testosterone levels were asymptomatic (e.g. in men 50+ yr, 47.6%). Crude prevalence of symptomatic androgen deficiency was 5.6% (95% confidence interval: 3.6%, 8.6%), and was not significantly related to race and ethnic group. Prevalence was low in men less than 70 yr (3.1–7.0%) and increased markedly with age to 18.4% among 70 yr olds. Projection of these estimates to the year 2025 suggests that there will be as many as 6.5 million American men ages 30–79 yr with symptomatic androgen deficiency, an increase of 38% from 2000 population estimates. Conclusions: Prevalence of symptomatic androgen deficiency in men 30 and 79 yr of age is 5.6% and increases substantially with age. The aging of the U.S. male population will cause a large increase in the burden of symptomatic androgen deficiency. Future work should address the clinical significance of low testosterone levels in asymptomatic men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The prevalence of symptomatic hypogonadism remains poorly defined, with estimates ranging from 2.1–17% in population-based surveys of men aged 30–87 years depending upon criterion utilized.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“However, many of these studies are hindered by heterogeneity in the definition for low fT (50–65 pg/ml [173.4–225.4 pmol/L]), with increases in the threshold for low fT resulting in higher sensitivity and reduced specificity when compared to TT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Other studies have also demonstrated increased associations between fT and other comorbid conditions, including depression and hypogonadal symptoms.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“Free T is also better indicator in young males as compared to elderly men, suggesting that the age-associated increase in SHBG may further reduce the specificity of fT.”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The authors noted that increasing the lower fT threshold (50–60, or 60–70pg/ml [173.4–208 and 208–242.7 pmol/L]) resulted in reduced specificity for symptoms such as low libido (28.1%, 23.9%, and 19.8% for 50, 60, and 70pg/ml [242.7 pmol/L], respectively).”
From Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials (2016) · cites this paper as [2]
In the citing paper
“The community prevalence estimates of potentially functional hypogonadism in middle-aged and older men (also referred to as late-onset, age-related, or adult-onset hypogonadism) vary from 2.1% to 12.3% (8–10)”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
In the citing paper
“In other observational studies of middle-aged and older men, symptoms and low testosterone also seldomly occurred together (Supplemental Fig. 1) (8–10).”
From A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management (2017) · cites this paper as [9]
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
Brown, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Biometrics · doi:10.2307/2532174 · Cited by 8,263
Koyak, R. A., Hastie, T. J., & Tibshirani, R. J. (1991) · Journal of the American Statistical Association · doi:10.2307/2290538 · Cited by 7,717
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationSödergard, R., Bäckström, T., Shanbhag, V., & Carstensen, H. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90038-3 · Cited by 1,080
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 722
Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism
Kim, J. W., & Moon, D. G. (2011) · Korean journal of urology · doi:10.4111/kju.2011.52.11.725 · Cited by 8
Rastrelli, G., & Forti, G. (2017) · Endocrinology · doi:10.1007/978-3-319-29456-8_31-1 · Cited by 8
van Os, J., Smit, D. L., Bond, P., & de Ronde, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1621558 · Cited by 7
Tsampoukas, G., Karna, S., Morgado, A., & Minhas, S. (2025) · International Journal of Impotence Research · doi:10.1038/s41443-025-01128-0 · Cited by 7
Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism
Wang, C., Zhang, H., Wang, F., Guo, J., Yuan, J., Hou, G., Gao, M., Li, Z., Zhang, Y., & on behalf of the Marco Polo Study Group on Sexual Health (MAPS-GOSH) (2023) · The Aging Male · doi:10.1080/13685538.2023.2288347 · Cited by 7
Kim, S. J., Lee, D., Park, S. G., Pak, S., Lee, Y. G., & Cho, S. T. (2023) · Neurourology and Urodynamics · doi:10.1002/nau.25371 · Cited by 7
Current state of practice regarding testosterone supplementation therapy in men with prostate cancer
Kovac, J. R., Pan, M. M., Lipshultz, L. I., & Lamb, D. J. (2014) · Steroids · doi:10.1016/j.steroids.2014.07.004 · Cited by 7
Lee, A., Rubinow, K. B., Clark, R. V., Caricofe, R. B., Bush, M., Zhi, H., Roth, M. Y., Page, S. T., Bremner, W. J., & Amory, J. K. (2012) · Journal of Andrology · doi:10.2164/jandrol.111.014514 · Cited by 7
Self-citationKong, X., Jiang, J., Cheng, B., & Jiang, R. (2019) · Andrologia · doi:10.1111/and.13344 · Cited by 7
The Association of Free Testosterone Levels in Men and Lifestyle Factors and Chronic Disease Status
Cardarelli, R., Singh, M., Meyer, J., Balyakina, E., Perez, O., & King, M. R. (2014) · Journal of Primary Care & Community Health · doi:10.1177/2150131913520234 · Cited by 7
Sun, Z. N. Y. F. A. Z. Y., Shen, W., Leers‐Sucheta, S., & Azhar, S. (2008) · Open Longevity Science · doi:10.2174/1876326x00802010076 · Cited by 7
Kim, C., Bebu, I., Braffett, B. H., Cleary, P. A., Arends, V. L., Steffes, M. W., Wessells, H., Orchard, T. J., & Sarma, A. V. (2015) · Clinical Endocrinology · doi:10.1111/cen.12990 · Cited by 7
Kula, K., & Słowikowska‐Hilczer, J. (2012) · Cited by 7
López, D. S., Wulaningsih, W., Tsilidis, K. K., Baillargeon, J., Williams, S., Urban, R. J., & Rohrmann, S. (2020) · HORMONES · doi:10.1007/s42000-020-00179-w · Cited by 7
Ishikawa, K., Tsujimura, A., Miyoshi, M., Miyoshi, Y., Ogasa, T., Hiramatsu, I., Uesaka, Y., Nozaki, T., Shirai, M., Kobayashi, K., et al. (2020) · International Journal of Urology · doi:10.1111/iju.14296 · Cited by 7
Testosterone Therapy: Increase in Hematocrit is Associated with Decreased Mortality
Strange, R. C., König, C. S., Ahmed, A., Hackett, G. I., Haider, A., Haider, K. S., Desnerck, P., Saad, F., Lorde, N., Maarouf, A., et al. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0019 · Cited by 7
IGF-1 levels are significantly correlated with patient-reported measures of sexual function
Pastuszak, A. W., Liu, J. S., Vij, A., Mohamed, O., Sathyamoorthy, K., Lipshultz, L. I., & Khera, M. (2011) · International Journal of Impotence Research · doi:10.1038/ijir.2011.31 · Cited by 7
Williams, B. R., & Cho, J. S. (2017) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2017.04.006 · Cited by 7
Burns, P. R., Kim, E. D., Ruff, D. D., & Seftel, A. D. (2015) · American Journal of Men s Health · doi:10.1177/1557988315609684 · Cited by 7
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Fosså, S. D., Bjerner, L. J., Tandstad, T., Brydøy, M., Dahl, A. A., Nome, R. V., Negaard, H. F. S., Myklebust, T. Å., & Haugnes, H. S. (2025) · European Urology Open Science · doi:10.1016/j.euros.2024.12.010 · Cited by 6
The occurrence of hypogonadotropic hypogonadism in Chinese men with type 2 diabetes
Zhou, Y., Tian, R., Wang, X., Sun, J., Zhu, L., & An, X. (2022) · Clinical Endocrinology · doi:10.1111/cen.14680 · Cited by 6
Tai, P. T., Nishijo, M., Van, M. P., Minh, P. N., Ngoc, T. P., Thị, H. V., Van, C. N., Ngoc, N. T., Minh, T. D., Duc, L. D., et al. (2024) · Environmental Science and Pollution Research · doi:10.1007/s11356-024-34364-w · Cited by 6
Reproductive endocrinology and aging in human males: An evolutionary perspective
Bribiescas, R. G. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105898 · Cited by 6
Mei, Y., Zhang, B., Chen, Y., Xu, R., Xue, D., Zhuang, Q., & Feng, X. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02015-x · Cited by 6
Can we rely on total testosterone measurement to exclude hypogonadism in erectile dysfunction?
Morgado, A., Silva, A. C., Diniz, P., & Silva, C. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00565-5 · Cited by 6
Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management
Livingston, M. A., & Heald, A. H. (2023) · Diagnostics · doi:10.3390/diagnostics13243650 · Cited by 6
Androgen deficiency syndrome in older people
Lee, Y. (2014) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12114 · Cited by 6
Traumatic andropause after combat injury
Jones, G. H., Kirkman‐Brown, J., Sharma, D. M., & Bowley, D. M. (2015) · BMJ Case Reports · doi:10.1136/bcr-2014-207924 · Cited by 6
Management of Hypogonadism in Cardiovascular Patients
Tanna, M. S., Schwartzbard, A. Z., Berger, J. S., Underberg, J. A., Gianos, E., & WEINTRAUB, H. S. (2016) · Urologic Clinics of North America · doi:10.1016/j.ucl.2016.01.011 · Cited by 6
Menadione perturbs oxidative stress biomarkers and testicular function indices of rats
Balogun, B. A., Aliyu, N. O., & Ajiboye, T. O. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22282 · Cited by 6
Schwarzman, L. S., de Souza, R. P., Ohlander, S. J., Mima, M., Abern, M. R., Andriole, G. L., Freedland, S. J., & Moreira, D. M. (2019) · Urology · doi:10.1016/j.urology.2019.11.004 · Cited by 6
Bulbocavernosus muscle area as a novel marker for hypogonadism
Gupta, N., Carvajal, M. M. T., Jurewicz, M., & Gilbert, B. R. (2016) · Asian journal of urology · doi:10.1016/j.ajur.2016.11.002 · Cited by 6
Tsuru, T., Tsujimura, A., Mizushima, K., Kurosawa, M., Kure, A., Uesaka, Y., Nozaki, T., Shirai, M., Kobayashi, K., & Horie, S. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210171 · Cited by 6
ABCD position statement on the management of hypogonadal males with type 2 diabetes
Dhatariya, K., Nagi, D. K., & Jones, T. H. (2010) · Practical Diabetes · doi:10.1002/pdi.1535 · Cited by 6
Rosen, R. C., Seftel, A. D., Ruff, D. D., & Muram, D. (2016) · American Journal of Men s Health · doi:10.1177/1557988315625773 · Cited by 6
Endocrine Laboratory Diagnosis
Simoni, M., & Nieschlag, E. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_7 · Cited by 6
Testosterone Deficiency: A Common, Unrecognised Syndrome?
Schulman, C. C., Fusco, F., Morales, A. M., Tostain, J., Vendeira, P., & Zitzmann, M. (2009) · European Urology Supplements · doi:10.1016/j.eursup.2009.05.003 · Cited by 6
Mortality Associated to Late-Onset Hypogonadism: Reasons Not to Treat With Testosterone?
Kaufman, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1103 · Cited by 6
Żylicz, Z. (2009) · Via Medica Journals · Cited by 5
Rastrelli, G., & Forti, G. (2017) · Endocrinology · doi:10.1007/978-3-319-44441-3_31 · Cited by 5
Livingston, M. A., Ramachandran, S., Hartland, A. J., Plant, A. J., Kirby, M. G., & Hackett, G. I. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2021.0029 · Cited by 5
Functional hypogonadism in men: key causes and neuroendocrine mechanisms of its development
Салухов, В. В., & Витальевна, А. С. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-210 · Cited by 5
Kuczera, P., Więcek, A., & Adamczak, M. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0042 · Cited by 5
López, D. S., Lee, W., Garcia, C. O., Downer, P., Taha, S. A., Tezanos, A. G. V., Tsilidis, K. K., Peek, M. K., Kyriakos, M., & Canfield, S. E. (2022) · HORMONES · doi:10.1007/s42000-022-00360-3 · Cited by 5
Li, F., Wang, C., Huang, J., Yang, W., Lan, B., Ding, C., Huang, C., Lao, G., Sun, K., Li, L., et al. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13513 · Cited by 7
Symptoms of testosterone deficiency in early middle aged men
Holm, A. S., Fredrikson, M. G., & Hammar, M. L. (2012) · The Aging Male · doi:10.3109/13685538.2012.669435 · Cited by 5
Allan, C. A., & McLachlan, R. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00139-8 · Cited by 5
Health, Evolution, and Reproductive Strategies in Men: New Hypotheses and Directions
Bribiescas, R. G., & Burke, E. E. (2017) · Springer eBooks · doi:10.1007/978-1-4939-4038-7_6 · Cited by 4
Moradi, S., Khazaeli, D., Dadfar, M., & Bakhtiari, N. (2022) · Nephro-Urology Monthly · doi:10.5812/numonthly.119131 · Cited by 4
Koyasu, H., Horie, S., Matsushita, K., Ashizawa, T., Muto, S., Isotani, S., Tanaka, T., Nakajima, M., & Tsujimura, A. (2022) · The World Journal of Men s Health · doi:10.5534/wjmh.210048 · Cited by 4
Examining the associations between testosterone and biomarkers as men age
Smith, S. J., Bekele, D., Lopresti, A. L., & Fairchild, T. J. (2023) · American Journal of Human Biology · doi:10.1002/ajhb.23942 · Cited by 4
Huang, W., Chen, M., Zhang, H., Zhang, Z., Yin, C., Huang, M., & Shi, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1369684 · Cited by 4
Min, K. S., & Kang, D. I. (2011) · Journal of Korean Medical Association · doi:10.5124/jkma.2011.54.2.197 · Cited by 4
The Role of Testosterone Therapy in Cardiovascular Mortality: Culprit or Innocent Bystander?
Tanna, M. S., Schwartzbard, A. Z., Berger, J. S., Alukal, J. P., & WEINTRAUB, H. S. (2015) · Current Atherosclerosis Reports · doi:10.1007/s11883-015-0490-0 · Cited by 4
Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction
Lowenstein, L., Shechter, A., Porst, H., Tripodi, F. M., & Reisman, Y. (2016) · International Journal of Impotence Research · doi:10.1038/ijir.2016.2 · Cited by 4
Zakaria, A. S., Dragomir, A., Kassouf, W., Tanguay, S., & Aprikian, A. G. (2018) · World Journal of Urology · doi:10.1007/s00345-018-2270-2 · Cited by 4
Chu, K. Y., Kulandavelu, S., Masterson, T. A., Ibrahim, E., Arora, H., & Ramasamy, R. (2020) · F&S Science · doi:10.1016/j.xfss.2020.03.002 · Cited by 4
Testosterone therapy: where do the latest guidelines agree and differ?
Pelzman, D. L., & Hwang, K. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000581 · Cited by 4
Testosterone deficiency syndrome among males with type 2 diabetes mellitus in East Malaysia.
Ahmad, S., Jerampang, P., Tohid, H., Ali, M. F., Jamil, T. R., & Ho, C. C. K. (2020) · PubMed Central · doi:10.18999/nagjms.82.4.613 · Cited by 4
Luteinizing Hormone Suppression Profiles in Men Treated with Exogenous Testosterone
Miranda, E., Schofield, E., Matsushita, K., Katz, D. J., Nelson, C. J., Benfante, N. E., & Mulhall, J. P. (2022) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2022.06.001 · Cited by 4
Lin, B., & Twigg, S. M. (2023) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-22-0242 · Cited by 4
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India
Kalra, S., Jacob, J. J., Unnikrishnan, A., Bantwal, G., Sahoo, A., Sahay, R. K., Jindal, S., Agrawal, M. S., Kapoor, N., Saboo, B., et al. (2023) · International Journal of Endocrinology · doi:10.1155/2023/4408697 · Cited by 4
Ishikawa, K., Tsujimura, A., Miyoshi, M., Miyoshi, Y., Ogasa, T., Hiramatsu, I., Uesaka, Y., Nozaki, T., Shirai, M., Kobayashi, K., et al. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0078 · Cited by 4
Kumar, R., Jhorawat, R., Mathur, M., Garsa, R. K., Kimmatkar, P., Sharma, S., Singh, A., Beniwal, P., & Malhotra, V. (2014) · Indian Journal of Transplantation · doi:10.1016/j.ijt.2014.08.002 · Cited by 4
[Diabetes mellitus and the syndrome of frailty in the elderly].
Navarrete‐Reyes, A. P., & Ávila‐Funes, J. A. (2010) · PubMed · Cited by 4
Testosterone Replacement—Freedom From Symptoms or Hormonal Shackles?
Ismaeel, N., & Wang, R. (2016) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2016.06.002 · Cited by 4
Lofrano‐Porto, A., Soares, E. D. M. K. V. K., Matias, A. A., Porto, L. G. G., & Smith, D. L. (2020) · Andrology · doi:10.1111/andr.12860 · Cited by 4
Reddy, R. S., Rivero, M., Patel, M., Muthigi, A., Diaz, P., & Ramasamy, R. (2022) · European Urology Focus · doi:10.1016/j.euf.2022.08.005 · Cited by 4
Borgert, B. J., Bacchus, M. W., Hernandez, A. D., Potts, S. N., & Campbell, K. J. (2023) · Sexual Medicine · doi:10.1093/sexmed/qfad004 · Cited by 4
[Hipogonadism. Global epidemiology and transversal relationships].
Martínez‐Jabaloyas, J. M. (2013) · PubMed · Cited by 4
Variability in total testosterone levels in ageing men with symptoms of androgen deficiency
Allan, C. A., Strauss, B. J., Forbes, E. A., Paul, E. M., & McLachlan, R. I. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01071.x · Cited by 4
Natural course of hypogonadism diagnosed during hospitalization in aged male patients
Iglesias, P., Prado, F., Muñoz, A., Guerrero, M. T., Macías, M. C., Ridruejo, E., Tajada, P., García-Arévalo, C., & Díez, J. J. (2014) · Endocrine · doi:10.1007/s12020-014-0417-5 · Cited by 5
Screening for Hypogonadism in Primary Healthcare: How to do this Effectively
Livingston, M. A., Jones, R. L., Hackett, G. I., Donnahey, G., Moreno, G., Duff, C. J., & Heald, A. H. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-114866 · Cited by 4
Lamberts, S. W. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00027-4 · Cited by 4
Hussain, M. A., Alam, M. N., Ahmed, N., Said, H., Afrin, S. F., Hassan, Z., Mamun, A. A., & Mahmood, A. K. A. (2019) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v19i1.43894 · Cited by 4
Reduced risk of ulcerative colitis after appendicectomy
Timmer, A., & Obermeier, F. (2009) · BMJ · doi:10.1136/bmj.b225 · Cited by 4
Behre, H. M. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00474-3 · Cited by 4
Behre, H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00265-4 · Cited by 4
Carlier, L., Chanson, P., Cazabat, L., Daclin, S., Salenave, S., Hage, M. P., Trabado, S., Young, J., & Maione, L. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae135 · Cited by 4
Manestar, D., Malvić, G., Velepic, M. M., Vukelić, J., Vrebac, I., Tudor, F., Vukelić, I., & Braut, T. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104062 · Cited by 3
Lee, J. Y., Kim, S., Kim, H., Yeon, S.-H., Kim, S., Son, R. H., Park, C. L., & Lee, Y. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0332 · Cited by 3
Li, D., Cheng, J., Zhang, W., Cheng, P., He, Y., Jia, J., Wang, C., Liu, Z., Sun, Z., & Wang, J. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240050 · Cited by 3
Phase II drugs currently being investigated for the treatment of hypogonadism
Udedibia, E., & Kaminetsky, J. C. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.948151 · Cited by 3
Zhou, S.-J., Zhao, M., Yang, Y., Guan, D., Li, Z.-G., Ji, Y.-D., Zhang, B.-L., Shang, X., Xiong, C., & Gu, Y. (2020) · American Journal of Men s Health · doi:10.1177/1557988320977991 · Cited by 3
Androgen Deficiency in the Aging Male
Morales, Á. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6911-9.00029-3 · Cited by 3
López, D. S., Taha, S. A., Gutierrez, S., Tezanos, A. G. V., Khalife, W. I., Alzweri, L. M., Markides, K. P., Baillargeon, J., & Tsilidis, K. K. (2022) · International Journal of Impotence Research · doi:10.1038/s41443-022-00660-7 · Cited by 3
Senescence and Late-Onset Hypogonadism
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer eBooks · doi:10.1007/978-3-031-31574-9_25 · Cited by 3
David, S. V., Gibson, D. C., Tezanos, A. G. V., Alzweri, L. M., Hernández‐Pérez, J. G., Torres‐Sánchez, L., Baillargeon, J., & López, D. S. (2023) · HORMONES · doi:10.1007/s42000-023-00506-x · Cited by 3
Iglesias, P., Prado, F., & Díez, J. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_8 · Cited by 3
An obese 48-year-old man with progressive fatigue and decreased libido
Farkouh, A., & Zayed, A. A. (2019) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.86a.18097 · Cited by 3
Enerji Metabolizması, Obezite ve Hormonlar
Ulutaş, D. S. S., Acar, N. E., & Yıldırım, İ. (2020) · Türkiye Spor Bilimleri Dergisi · doi:10.32706/tusbid.719671 · Cited by 3
Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men
Wang, S.-K., Lee, M., Hung, C.-L., Chen, H.-H., Liao, C., & Chiu, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265629 · Cited by 3
Thompson, A., Omil-Lima, D., Perez, J. A., Jesse, E., Khera, M., Chavin, K. D., & Thirumavalavan, N. (2024) · International Journal of Impotence Research · doi:10.1038/s41443-024-00921-7 · Cited by 3
Sexual Dysfunction in Chronic Kidney Disease
Dancik, T., No, G., & Johansen, K. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411602-3.00029-9 · Cited by 4
Kaufman, J., T'Sjoen, G. G., & Vermeulen, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003353.017 · Cited by 3
The use of hormonal therapy in “andropause”: the con side
Casey, R. W. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.527 · Cited by 3
The use of hormonal therapy in “andropause”: the pro side
Morales, Á. (2013) · Canadian Urological Association Journal · doi:10.5489/cuaj.526 · Cited by 3
Study clarifies associations between hypogonadism and health in aging men
Amory, J. K. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.78 · Cited by 3
Testosterone testing in adult males.
Ho, C. K. M. (2011) · PubMed · Cited by 3
Jones, T. H. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03737.x · Cited by 3
Metadata
- Authors
- Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B.
- Affiliations
- New England Research Institutes, Inc. (A.B.A., G.R.E., V.K., A.B.O., T.G.T., J.B.M.), Watertown, Massachusetts 02472
- New England Research Institutes (US)
- GlaxoSmithKline (United States) (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-11-01
- Volume
- 92
- Issue
- 11
- Pages
- 4241-4247
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2135798327
- Cited by
- 720
- References
- 45
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 23 · 2023: 31 · 2022: 46 · 2021: 30 · 2020: 40 · 2019: 29 · 2018: 28 · 2017: 46 · 2016: 58 · 2015: 49 · 2014: 57 · 2013: 48 · 2012: 45
- FWCI
- 25.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG020727)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK56842)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen deficiency, free testosterone, prevalence, men, low libido, erectile dysfunction, osteoporosis, sex hormone-binding globulin, age-related decline, racial and ethnic differences, sex steroid levels, sleep disorders, depressive mood, physical performance, men's health, older men
- MeSH terms
- Adult, Aged, Androgens, Boston, Data Interpretation, Statistical, Endocrine System Diseases, Ethnicity, Humans, Male, Middle Aged, Gonadal Steroid Hormones, Testosterone, Cluster Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
